Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Glaxosmithkline (GSK)

Price 1,663.50p on 10-09-2024 at 05:00:06
Change 0.00p 0%
Buy 1,680.00p
Sell 1,650.00p
Buy / Sell GSK Shares
Last Trade: Buy 96,901.00 at 1,678.68p
Day's Volume: 0
Last Close: 1,663.50p
Open: 0.00p
ISIN: GB00BN7SWP63
Day's Range 0.00p - 0.00p
52wk Range: 1,376.00p - 1,820.00p
Market Capitalisation: £67,854m
VWAP: 0.00p
Shares in Issue: 4,079m

Recent Trades History Glaxosmithkline (GSK)

Buy/Sell Volume Trade Prc Trade Type Trade Time
Buy* 96,901 1,678.68p Suspected BUY Trade
15:39:58 - 09-Sep-24
Sell* 200,000 1,663.50p SI Trade
15:35:23 - 09-Sep-24
Sell* 200,000 1,663.50p SI Trade
15:35:23 - 09-Sep-24
Sell* 6,016 1,663.50p SI Trade
15:35:03 - 09-Sep-24
Sell* 5,160 1,663.50p Automatic Execution
15:35:03 - 09-Sep-24
Unknown* 1,902 1,663.50p OTC Trade
15:35:03 - 09-Sep-24
Unknown* 211 1,663.50p OTC Trade
15:35:03 - 09-Sep-24
Buy* 2,298 1,663.50p SI Trade
15:35:03 - 09-Sep-24
Sell* 2,580 1,663.50p Automatic Execution
15:35:03 - 09-Sep-24
Buy* 1,536,032 1,663.50p Suspected BUY Trade
15:35:03 - 09-Sep-24

Share Price History for Glaxosmithkline

Time period:
to
Date Open High Low Close Volume

Share News for Glaxosmithkline

TRADING UPDATES: Live Co fails to reach agreement with creditor

9th Sep 2024 22:02

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News: Read More

EXECUTIVE CHANGES: Invinity replaces CEO; Gulf Keystone chair dies

6th Sep 2024 11:47

(Alliance News) - The following is a round-up of London-listed company director and manager changes announced on Thursday and Friday and not separately reported by Alliance News: Read More

GSK hails positive results of Nucala clinical trials in lung disease

6th Sep 2024 09:38

(Alliance News) - GSK PLC on Friday announced positive headline results of the Matinee phase III clinical trial evaluating Nucala. Read More

LONDON MARKET MIDDAY: Stocks tick higher as investors prep for US GDP

29th Aug 2024 11:51

(Alliance News) - Stock prices in London were higher at midday on Thursday, as the market looks ahead to a handful of economic data from the US later today. Read More

TOP NEWS: GSK hails EU approval of RSV jab Arexy for 50-59 year olds

29th Aug 2024 10:37

(Alliance News) - GSK PLC on Thursday announced that the European Commission has authorised Arexvy, its respiratory syncytial virus vaccine, for adults aged 50 to 59 who are at increased risk. Read More

FTSE 100 Latest
Value8,270.84
Change0.00

Login to your account

Forgot Password?

Not Registered